Sunshine Biopharma Inc. (SBFM)
NASDAQ: SBFM
· Real-Time Price · USD
1.47
-0.04 (-2.65%)
At close: Aug 15, 2025, 12:27 PM
Sunshine Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 36.23M | 34.87M | 32.96M | 30.48M | 26.74M | 24.09M | 20.35M | 14.53M | 9.12M | 4.35M | 490.88K | 408.45K | 311.01K | 228.43K | 171.32K | 138.09K | 100.37K |
Cost of Revenue | 25.24M | 24.3M | 22.95M | 21.35M | 17.96M | 15.8M | 13.09M | 9.19M | 5.66M | 2.65M | 261.6K | 215.32K | 159.16K | 117.83K | 67K | 53.84K | 40.48K |
Gross Profit | 11.09M | 10.67M | 10.05M | 9.18M | 8.82M | 8.34M | 7.26M | 5.34M | 3.46M | 1.7M | 229.28K | 193.12K | 151.86K | 110.6K | 104.32K | 84.26K | 59.88K |
Operating Income | -5.71M | -5.76M | -4.91M | -4.58M | -4.33M | -4.81M | -26.99M | -27.93M | -27.61M | -27M | -3.92M | -2.7M | -2.39M | -2.44M | -2.5M | -2.08M | -1.81M |
Interest Income | 427.28K | 496K | 584.31K | 683.13K | 742.18K | 811.97K | 736.03K | 789.53K | 732.53K | 518.65K | 406.98K | 146.05K | 3.00 | n/a | n/a | n/a | n/a |
Pretax Income | -5.33M | -5.37M | -4.11M | -3.74M | -3.72M | -4.11M | -26.36M | -27.21M | -26.93M | -26.51M | -2.56M | -5.15M | -7.49M | -12.44M | -14.19M | -10.85M | -8.88M |
Net Income | -5.03M | -5.13M | -4.23M | -3.68M | -4.09M | -4.5M | -26.77M | -27.57M | -27.21M | -26.74M | -2.56M | -5.15M | -7.49M | -12.44M | -14.19M | -10.85M | -8.88M |
Selling & General & Admin | 15.16M | 14.89M | 12.9M | 11.62M | 11.07M | 10.83M | 14.42M | 13.4M | 11.68M | 9.48M | 3.28M | 2.16M | 1.66M | 1.87M | 2.01M | 1.79M | 1.69M |
Research & Development | -7.13K | -370 | 1.6M | 1.71M | 1.64M | 1.86M | 1.08M | 1.21M | 883.13K | 811.86K | 861.29K | 721.26K | 867.08K | 672.21K | 641.96K | 419.49K | 227.73K |
Other Expenses | 174.74K | -227 | 219.34K | 188.04K | 122.89K | 221.32K | 393.96K | 304.95K | 175.71K | 80.4K | 9.37K | 11.76K | 12.67K | 12.74K | 13.1K | 13.44K | 13.74K |
Operating Expenses | 16.64M | 16.27M | 14.63M | 13.43M | 12.8M | 12.79M | 34.22M | 33.24M | 31.07M | 28.7M | 4.15M | 2.89M | 2.54M | 2.55M | 2.61M | 2.16M | 1.87M |
Interest Expense | 8.77K | 57.95K | 79.54K | 118.06K | 121.15K | 113.04K | 109.48K | 70.95K | 67.62K | 39.41K | 49.49K | 96.34K | 291.97K | 328.82K | 397.63K | 372.87K | 201.46K |
Selling & Marketing Expenses | 1.14M | 940.28K | 968.38K | 927.53K | 804.38K | 734.25K | 680.69K | 656.46K | 610.96K | 578.09K | 400.39K | 182.72K | 95.04K | n/a | 191.5K | 191.5K | 243.5K |
Cost & Expenses | 41.94M | 40.64M | 37.87M | 35.07M | 31.05M | 28.88M | 47.31M | 42.43M | 36.72M | 31.35M | 4.41M | 3.1M | 2.7M | 2.67M | 2.68M | 2.21M | 1.92M |
Income Tax Expense | -297.94K | -235.43K | 113.84K | -60.43K | 371.25K | 395.17K | 408.2K | 367.23K | 279.55K | 233.29K | -16 | 9.00 | 9.00 | n/a | n/a | n/a | -6.3K |
Shares Outstanding (Basic) | 2.7M | 2.58M | 1.27M | 49.73K | 32.06K | 11.94K | 12.85K | 1.27M | 11.01K | 22.35M | 188.86K | 7.92K | 5.27M | 3.58M | 2.54M | 2.39M | 2.19M |
Shares Outstanding (Diluted) | 2.7M | 2.58M | 1.27M | 49.73K | 32.06K | 11.94K | 12.85K | 1.27M | 11.02K | 22.59M | 188.86K | 7.92K | 5.27M | 3.58M | 2.54M | 2.39M | 2.19M |
EPS (Basic) | 32.28 | -7.32 | -155.61 | -205.39 | -196.16 | -310.73 | -207.09 | -316.37 | -375.66 | -681.05 | -679.35 | -3.7K | -6.06K | -11.24K | -11.25K | -8.98K | -7.91K |
EPS (Diluted) | 32.28 | -7.32 | -155.61 | -205.39 | -196.16 | -310.63 | -206.98 | -316.26 | -375.55 | -690.02 | -688.33 | -3.71K | -6.07K | -11.24K | -11.25K | -8.98K | -7.91K |
EBITDA | -5.07M | -5.09M | -3.83M | -3.45M | -3.41M | -3.82M | -26.1M | -27.02M | -26.81M | -26.45M | -2.51M | -5.04M | -7.18M | -12.09M | -13.78M | -10.46M | -8.66M |
EBIT | -5.32M | -5.31M | -4.03M | -3.62M | -3.57M | -3.97M | -26.23M | -27.11M | -26.86M | -26.47M | -2.52M | -5.05M | -7.2M | -12.11M | -13.79M | -10.47M | -8.67M |
Depreciation & Amortization | 245.7K | 223.53K | 200.47K | 173.05K | 157.06K | 149.15K | 125.77K | 89.35K | 56.76K | 25.16K | 9.37K | 11.76K | 12.67K | 12.74K | 13.12K | 13.44K | 13.42K |